Brought to you by 
Schein to buy Marsam for $240 million
13 Jul 1999
Executive Summary
Schein Pharmaceutical agreed to buy Marsam Pharmaceuticals (generic injectables) for $21 per share in a cash transaction totalling $240 million. Marsam closed at around $20 on 7/28/95.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Schein to buy Marsam for $240 million
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice